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Pre-existing chronic hypotension affects a percentage of kidney transplanted patients
(KTs). Although a relationship with delayed graft function (DGF) has been hypothesized,
available data are still scarce and inconclusive.
Methods
A monocentric retrospective observational study was performed on 1127 consecutive KTs
from brain death donors over 11 years (2003–2013), classified according to their pre-trans-
plant Mean Blood Pressure (MBP) as hypotensive (MBP < 80 mmHg) or normal-hyperten-
sive (MBP� 80 mmHg, with or without effective antihypertensive therapy).
Results
Univariate analysis showed that a pre-existing hypotension is associated to DGF occur-
rence (p<0.01; OR for KTs with MBP < 80 mmHg, 4.5; 95% confidence interval [CI], 2.7 to
7.5). Chronic hypotension remained a major predictive factor for DGF development in the
logistic regression model adjusted for all DGF determinants. Adjunctive evaluations on
paired grafts performed in two different recipients (one hypotensive and the other one nor-
mal-hypertensive) confirmed this assumption. Although graft survival was only associated
with DGF but not with chronic hypotension in the overall population, stratification according
to donor age revealed that death-censored graft survival was significantly lower in hypoten-
sive patients who received a KT from >50 years old donor.
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Conclusions
Our findings suggest that pre-existing recipient hypotension, and the subsequent hypoten-
sion-related DGF, could be considered a significant detrimental factor, especially when
elderly donors are involved in the transplant procedure.
Introduction
Kidney transplantation is the best option for end-stage kidney disease (ESKD) treatment,
improving both patients’ survival and quality of life. Even though chronic hypotension signifi-
cantly affects ESKD patients, few studies limited to specific time-point (i.e., intraoperative
hypotension) or subsets (non-heart-beating/young living donors) [1–6] are focused on its
potential role in influencing graft outcomes.
At the same time, the definition of hypotension is a matter of debate: for example, low
blood pressure without a documented causative factor (“constitutional hypotension”) is a dis-
puted diagnostic entity [7]. Although literature studies generally evaluated mean blood pres-
sure (MBP), no threshold value is universally accepted (ranging from 70 to 90 mmHg), with
no consensus on whether this cut-off may vary according to age/gender [7, 8].
However, some reports suggest a higher risk of delayed graft function (DGF) secondary to a
hypotension-mediated reduction in renal blood flow [9–11]. DGF, as well-known, negatively
affects graft outcomes, including increased short- and long-term morbidity and mortality, allo-
graft immunogenicity, acute rejection, hospitalization rates, and costs [1, 12–14].
Our study aims to investigate the effect of pre-existing recipient hypotension on both DGF
and long-term allograft outcomes in kidney transplanted patients (KTs).
Materials and methods
Study design
We performed a retrospective study on 1127 patients who received their KT from brain death
donors (DBD) at the Renal Transplant Center “A. Vercellone,” AOU Città Della Salute e Della
Scienza Hospital, Turin thorough an observational period of 11 years (from January 2003 to
December 2013).
For every patient, blood pressure (BP) was measured using automatically inflated cuffs
using a digital monitor; BP evaluation was made by health workers several times for every
patient to ensure reliability and avoid values altered by emotionalism. We also considered
recent BP data from their dialytic records and measurement in their waiting list schedule for
patients not on antihypertensive treatment.
Based on the concordance of current values and clinical diary of the last three pre-trans-
plant months, mean blood pressure (MBP) was calculated using the formula: MBP = [(2�DBP)
+ SBP]/3.
Because no guideline defines the exact cut-off value in KTs, we set the hypotension thresh-
old at 80 mmHg according to available experiences [4, 9, 10, 15].
Thereafter, patients were divided in hypotensive (MBP < 80 mmHg; n = 65, 5.8%), normo-
tensive (MBP� 80; n = 127, 11.2%) and hypertensive group (MBP� 80 with at least one anti-
hypertensive medication, n = 935, 83%).
Before KT, all patients were on follow-up in their dialysis centers for a minimum of one
year; filed medical documentation is available for every patient.
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The recipients’ follow-up was performed with scheduled clinical visits or hospital admis-
sions when significant complications occurred. Data were collected from the patients’ charts.
Furthermore, we evaluated donor age, gender, cardiovascular cause of death, hypertension,
creatinine, KDPI and estimated glomerular filtration rate (eGFR, CKD-EPI formula) at time
of organ procurement, cold ischemia time (CIT), recipient characteristics (age, gender, type of
dialysis, hypertension, time spent on dialysis), and available perioperative MBP values at spe-
cific time-points (before, at reperfusion, and after surgery).
DGF was defined as the need for hemodialysis (established on a clinical basis) within the
first post-transplant week.
The same group of trained pathologists analyzed all available kidney biopsies throughout
the study period.
The study was performed in adherence to the last version of the Helsinki Declaration and
the Principles of the Declaration of Istanbul on Organ Trafficking and Transplant Tourism.
None of the transplant donors was from a vulnerable population; according to Italy legal sys-
tem (Law no. 91/1999 and Ministry of Health Decrees 8/04/2000-11/4/2008), all adult citizens
are offered the possibility (not the obligation) of giving or withdrawing their consent to the
donation of organs and tissues after death. In the case of a potential donor (i.e., a person who
has been pronounced dead), the re-suscitation team will verify whether the person carries a
document containing a statement of intent, or whether such a statement been registered in the
online database. If a citizen has not stated his/her intention while alive, the law allows the
donor next of kin to withdraw consent to organ removal while death is being ascertained.
All KT recipients signed informed consent, including their permission to have data from
their medical records used in research. This study is covered by our Ethical Committee (Comi-
tato Etico Interaziendale A.O.U. Città Della Salute e Della Scienza di Torino—A.O. Ordine
Mauriziano—A.S.L. Città di Torino) approval, resolution number 1449/2019 on 11/08/2019
(“TGT observational study”).
Immunosuppressive regimen and perioperative management
Immunosuppressive protocols were homogeneous for the whole study period: induction was
mainly conducted with anti-CD25 and steroids; calcineurin inhibitor, mycophenolate mofetil,
and steroids were mostly adopted as maintenance immunosuppression. In patients who
received KT from extended criteria donors (ECD), calcineurin inhibitors were introduced
after functional graft recovery (usually at serum creatinine� 2,5 mg/dL). Steroid dosage was
500 mg, 200 mg, 50 mg, and 20 mg, respectively, on days 1, 2, 3, 4 after KT, with subsequent
tapering in 45–60 days.
Management of suboptimal blood pressure during intervention was also similar in the over-
all population and composed by initial crystalloid infusions with subsequent dopamine adop-
tion (usually 2.5 μg/kg/min) in persistent MBP<80 mmHg.
Statistical analysis
Discrete data were described as percentages and analyzed with the Pearson chi-square test or,
for small samples, the Fisher exact test. The odds ratios (OR [CI 95%]) were used to measure
relative risk. Continuous variables were described as mean ± standard deviation, when normal,
and median (25th; 75th percentile), when non-normally distributed. Mann-Whitney, Kruskal-
Wallis, or t-test was used when appropriate. Cumulative graft and patient survival were ana-
lyzed by Kaplan-Meier (KM) curves and the Log Rank test. Cox analysis was used for the mul-
tivariate model. Relevant variables were checked first in univariate analysis and then including
multivariate analysis (logistic regression); for some continuous variables, the cut-off value was
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set based on ROC curve results. The paired kidney analysis accounts for couples (n = 18) of
recipients at their first KT transplanted in our center (one hypotensive and one normal/hyper-
tensive). All statistical analyses were performed using SPSS software (IBM SPSS Statistics, vers.
25.0.0). A significant level for all tests was set at p<0,05.
Results
Characteristics of the studied population and the role of DGF
Table 1 detailed the clinical and demographic characteristics of our population.
Briefly, DGF was observed in 310 patients (28.5%); in these KTs, KM curves showed signifi-
cant (p<0.001) low allograft (at 5 years 71.3% in DGF group vs. 87.9% in no DGF), patient
(84% vs. 94.8%) and death-censored graft survival (80.4% vs. 91.6%) (Fig 1).
As expected, KTs who experienced DGF also had a worse renal function at any follow-up
time (Fig 2).
Statistically significant associations with increased DGF risk were noted by univariate anal-
ysis for some recipient (age, history of previous KT� 1, hemodialysis) and donor characteris-
tics (age, death for a cardiovascular cause, hypertension, eGFR, CIT) (p = 0.01 for all these
variables). As shown in Table 2, the no-DGF group was composed of younger recipients who
received KT from younger donors, often without hypertension or death for a cardiovascular
cause. Donor eGFR is consequently higher in the no-DGF group and, likewise, CIT is lower
than in KTs who experienced DGF.
Interestingly, a close and significant correlation between pre-existing hypotension and
DGF was already observed.
Table 1. Clinical and demographic characteristics of the studied population.
Characteristics All patients (n = 1127)
Recipient gender M/F, n (%) 721 (64) / 406 (36)
Recipient age, yrs 53.8 ± 11,9
Recipient hypertension, n (%) 934 (82.9)
HD, n (%) 880 (78.1)
PD, n (%) 247 (21.9)
Time spent on dialysis, yrs 3.9 (2.7–6.7)
Type of transplantation (SKT/DKT), n (%) 1082 (96) / 45 (4)
Previous KT (0 /� 1), n (%) 972 (86.2) / 155 (13.8)
Donor gender M/F, n (%) 578 (51.3) / 549 (48.7)
Donor age, yrs 57.3 ± 15.6
Donor hypertension, n (%) 544 (48.3)
Donor eGFR (CKD-EPI), mL/min/1.73m2 89 ± 28
Donor death for cardiovascular cause, n (%) 811 (72.0)
KDPI�85%, n (%) 545 (48.3)
CIT, h 17.0 [14.0–20.3]�
DGF, n (%) 310 (28.5)��
� median [25˚-75˚ percentile]
�� evaluated on available data (n = 1088)
sCr: Creatinine; SKT: Single Kidney Transplantation; DKT: Dual Kidney Transplantation; HD: Hemodialysis; PD:
Peritoneal Dialysis; DGF: Delayed Graft Function; CIT: cold ischemia time
https://doi.org/10.1371/journal.pone.0249552.t001
PLOS ONE Recipient hypotension and delayed graft function in kidney transplantation
PLOS ONE | https://doi.org/10.1371/journal.pone.0249552 April 5, 2021 4 / 15
Fig 1. Graft and patient survival by DGF in the studied population. Graft, patient, and death-censored graft survival
were all reduced in patients who experienced DGF (p<0.001 in all analyses).
https://doi.org/10.1371/journal.pone.0249552.g001
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Fig 2. Renal function in studied population according to DGF occurrence. KTs who experienced DGF had a low eGFR
(CKD-EPI formula) vs. no DGF patients at any time-point. �p<0.001.
https://doi.org/10.1371/journal.pone.0249552.g002
Table 2. Factors associated with DGF (univariate analysis).
no DGF (71.5%) DGF (28.5%) p
Recipient gender (M/F), % 64,4 / 35,6 61 / 39 0.3
Recipient age, yrs 54 (45–62) 57 (49–75) 0.01
MBP <80 mmHg, % 3,2 / 96,8 12,9 / 87,1 <0.001
PD / HD, % 25.9 / 74.1 10.8 / 89.2 <0.001 [OR for HD, 2.9
(1.9–4.4)]
Time spent on dialysis, yrs 3.3 (1.9–5.8) 5.4 (3.1–7.9) <0.001
Previous KT (0 /� 1), % 89,5 / 10,5 79,7 / 20,3 < 0.001 [OR, 2.2 (1.5–3.1)]
Donor gender (M/F), % 50,1 / 49,9 53,9 /46,1 0,283
Donor age, yrs 58 (46–69) 63,5 (50–72) <0.001
Donor cause of death (cardiovascular/trauma/
other), %
67,7 / 24,3 / 8 81,4 / 13,1 / 5,5 <0.001
Donor hypertension (no/yes), % 55,9 / 44,1 43,5 / 56,5 < 0.001 [OR, 1.6 (1.2–2.2)]





CIT, h 16.8 (14.0–20.0) 17.2 (14.7–20.9) 0.01
MBP: Mean Blood Pressure; HD: Hemodialysis; PD: Peritoneal Dialysis; eGFR: estimated glomerular filtration rate;
CIT: cold ischemia time
https://doi.org/10.1371/journal.pone.0249552.t002
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Association between pre-existing hypotension and DGF
As shown in Fig 3, DGF incidence was increased in the hypotensive vs. normal-hypertensive
group (p<0.001; OR for Hypotension, 4.5; 95% confidence interval [CI], 2.7 to 7.5). This dif-
ference remained significant when separating normotensive and hypertensive KTs (Table 3),
stressing the importance of a hypotension causative role in DGF occurrence.
To confirm the role of hypotension in our population and to reduce the effect of possible
confounders variables, we stratified KT characteristics according to blood pressure status
(Table 4); groups were quite superimposable except for reduced donor age, longer time spent
on dialysis, and a higher percentage of the female gender and previous hemodialytic patients
in hypotensive KTs.
The significant association between DGF and blood pressure status was confirmed by mul-
tivariate analysis including all factors associated with DGF occurrence (Table 5): patients in
the hypotensive group had the higher risk of experiencing DGF (OR, 5.4; 95% confidence
interval [CI], 2.8 to 10.6).
Hypotension-related DGF may influence death-censored graft survival in
KT from elderly donors
Based on the demonstration of an association between pre-existing hypotension and DGF, we
consequently investigated the possible long-term effects of blood pressure status on graft and
patient survival.
In the KM model, graft, patient, and death-censored survival were similar between groups
(Fig 4); similarly, eGFR did not differ between hypotensive and normal-hypertensive KT (Fig
5).
Fig 3. DGF incidence in the hypotensive, normotensive, and hypertensive group. DGF incidence was higher in the
hypotensive group vs. normotensive and hypertensive groups (p<0.001).
https://doi.org/10.1371/journal.pone.0249552.g003
Table 3. DGF incidence according to pre-existing blood pressure status.
no DGF (71.5%) DGF (28.5%) P
Hypotensive group 25/65 (38,5%) 40/65 (61,5%) < 0.01
Normotensive group 93/127 (73,2%) 34/127 (26,8%)
Hypertensive group 660/896 (73,7%) 236/896 (26,3%)
https://doi.org/10.1371/journal.pone.0249552.t003
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Nevertheless, an association between hypotension and death-censored graft survival
emerged considering KTs from elderly donors. Through a stratified analysis by exploiting
donor age tertiles (�50, 51–66 and�67 yrs), we found that death-censored graft survival was
significantly reduced (p = 0.04) in the hypotensive patients who received KT from a
donor > 50 yrs (78% of functioning graft in the hypotensive group at 5 yrs vs. 87.4% in the
normal-hypertensive group for donor age 51–66; 58.3% vs. 82% for donor age� 67 yrs, respec-
tively) (Fig 6).
Multivariate Cox regression analysis demonstrated that DGF and donor age were the only
independent risk factors for death-censored graft survival reduction, suggesting the role of
hypotension-induced DGF in this scenario (Table 6).
Pre-existing hypotension is both associated with DGF in paired kidneys
and with perioperative hypotension
We also performed a confirmatory analysis investigating KTs among paired kidneys with one
hypotensive and one normal-hypertensive recipient, identifying 18 couples treated with the
same induction therapy (anti-CD25 antibody and steroids): as for the overall population, DGF
Table 4. Characteristics of the studied population according to pre-existing blood pressure status.
Hypotensive (5.9%) Normal-hypertensive (94.1%) p
Recipient gender (M/F), % 47 / 53 65 / 35 0.005
Recipient Age, yrs 51.5 (42–62.25) 55 (46–63) 0.207
PD/HD, % 5.7 / 94.3 23 / 77.0 0.001
Previous KT (0/�1), % 75.8 / 24.2 86.9 / 13.1 0.016
Donor gender (M/F), % 51.5 / 48.5 51.3 / 48.7 0.999
Donor age, yrs 48 (39–64.25) 60 (48–70) <0.001
Donor cause of death (cardiovascular/trauma/other), % 68.3 / 25 / 6.7 72.2 / 20.6 / 7.2 0.688
Donor hypertension (no/yes), % 56.1 / 43.9 51.4 / 48.6 0.525
Donor eGFR, ml/min/1.73m2 96.0 (73.8–117.2) 91.8 (69.9–107.7) 0.130
CIT, h 16 (13.5–19.5) 17 (14–20.3) 0.233
Time spent on dialysis, yrs 6.0 (3.4–8.7) 3.8 (2.1–6.6) <0.001
HD: Hemodialysis; PD: Peritoneal Dialysis; eGFR: estimated glomerular filtration rate; CIT: cold ischemia time
https://doi.org/10.1371/journal.pone.0249552.t004
Table 5. Factors associated with DGF (multivariate analysis).
P H.R. 95% C.I. per EXP(B)
Inferior Superior
MBP<80 mmHg <0.001 5.4 2.8 10.6
Donor death for a cardiovascular cause, n (%) 0.002 1.9 1.3 2.8
Donor age (>60 yrs) 0.008 1.7 1.1 2.4
Time spent on dialysis (� 4 yrs) <0.001 2.1 1.5 2.9
CIT 0.889 1 1 1
Previous KT (� 1) 0.078 1.2 0.9 2.4
Recipient age (� 50 yrs) 0.220 1.3 0.9 1.9
Dialysis type (HD vs. PD) <0.001 2.9 1.8 4.8
Donor hypertension 0.195 1.3 0.9 1.8
MBP: Mean blood pressure; CIT: cold ischemia time; KT: kidney transplant
https://doi.org/10.1371/journal.pone.0249552.t005
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Fig 4. Graft and patient survival by pre-existing blood pressure status in the studied population. No difference was
noted between the hypotensive and normal-hypertensive groups (p = NS in all analyses).
https://doi.org/10.1371/journal.pone.0249552.g004
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incidence was significantly higher in patients with pre-existing hypotension [(66.7% vs. 22.2%
in Normal-hypertensive KT; p = 0.02, OR 7.0 (1.6–30.8)] without differences in recipient age,
CIT, graft, or patient survival.
Considering perioperative data (available in 917/1127, S1 File, sheet 2), we found a concor-
dance between “historical” hypotension and an MBP<80 mmHg immediately before, during
(at reperfusion), or after the surgery (K = 0.616); however, pre-existing hypotension showed a
better associated with DGF [OR for perioperative hypotension 2.8 (1.9–4.1)].
Additionally, patients in the hypotension group also had an increased risk of receiving a
perioperative fluid administration > 3000 mL (37.9% vs. 13.9% in normal-hypertensive;
p<0.001).
Discussion
Renal function is intrinsically related to hemodynamic status. Autoregulation allows kidneys
to maintain normal blood flow and glomerular filtration rate between a mean systemic arterial
pressure from 80 mmHg to 160 mmHg [16]. However, in the first post-transplant period,
some critical stress factors (i.e., ischemia-reperfusion injury, exposure to vasoconstrictors such
as calcineurin inhibitors) may impair this system [4, 17], so the effect of hypotension could be
further aggravated with a significant reduction in renal blood flow.
However, few studies have specifically investigated the possible consequences of recipient
hypotension in graft and patient outcomes, often limiting their considerations to perioperative
management or short-term post-transplant period.
Fig 5. Renal function in studied population according to pre-existing blood pressure status. No difference was noted between the
hypotensive and normal-hypertensive groups during the follow-up (p = N.S. at any time-point).
https://doi.org/10.1371/journal.pone.0249552.g005
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Fig 6. Death-censored graft survival by pre-existing blood pressure status and stratified by donor age. Death-
censored graft survival was reduced in patients with pre-existing hypotension who received a kidney from a donor
between 51 and 66 yrs (p = 0.04) or� 67 yrs (p = 0.04).
https://doi.org/10.1371/journal.pone.0249552.g006
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In our study, we found that pre-existing chronic hypotension (defined as an MBP<80
mmHg assessed during a three months pre-transplant period) is a crucial detrimental factor
because a) it significantly and independently correlates to DGF, also in paired kidney analysis
among KTs with discordant blood pressure status (hypotensive vs. normal-hypertensive); b) in
KTs from elderly donors it may contribute to a low death-censored graft survival due to hypo-
tension-related DGF; c) it is associated with documented intraoperative hypotensive episodes
and perioperative fluid administration > 3000 mL with a better correlation to DGF than peri-
operative values.
Even though DGF is broadly considered a harmful condition with a significant negative
impact on graft and patient survival [18–22], its relationship with hypotension is debated.
In 2000, Boom [1] reported that recipients with MBP below 100 mmHg before transplanta-
tion had a doubled risk of DGF. However, the studied population (CIT 29±7 h, donor age 37
±14 yrs, recipient age 46±13 yrs) was quite different from standard real-life settings.
Ozdemir et al. [2] associated a systolic blood pressure<120 mmHg to an increased risk of
DGF in living-related renal allograft recipients: these data again involved a limited population
(KTs from living donors) with a younger age than typically observed in current practice.
Our data are closely related to those reported by Gingell-Littlejohn et al. [11] and Kauf-
mann et al. [9]. Both studies identified a correlation between intraoperative MBP and DGF
occurrence, despite targets and cut-offs varied between studies [any recorded MBP<70
mmHg and an MBP <80 mm Hg at the time of reperfusion, respectively]. As for Webber et al.
[4], who adopted our definition observing the highest risk of PNF for patients with MBP <80
mmHg, the high OR identified by multivariate analysis and confirmed in both paired kidneys
and perioperative data analyses suggest that, besides being only related to intraoperative hypo-
tension, chronic pre-existing blood pressure status may better describe a high-risk profile of
KTs who may develop DGF.
Additionally, to the best of our knowledge, our study is the first to deeply evaluate long-
term graft and patient survival stratifying population according to pre-existing blood pressure
status and with the absence of confounding factors such as extensive percentage of living dona-
tion or donors after cardiac deaths.
We did not find an association between hypotension and graft or patient survival on the
overall population and paired kidneys. However, sorting out the population by donor age,
hypotensive patients who received KT from a donor >50 yrs had a reduced death-censored
graft survival; according to multivariate Cox regression analysis, where only DGF and donor
age remain significant, we speculate that DGF-mediated hypotension may particularly exert its
negative effect in this frail subset of KTs, identifying a subgroup of patients where targeted
blood pressure monitorization acquires the highest importance.
Our results effectively emphasize the need for rational peri- and postoperative fluid man-
agement to maintain adequate kidney perfusion without a maximization of cardiac filling;
however, as reported in literature and observed in current practice, this target remains a
Table 6. Multivariate Cox regression analysis.
P H.R. 95% C.I. per EXP(B)
Inferior Superior
MBP<80 mmHg 0.146 1.593 0.851 2.984
DGF <0.001 2.177 1.599 2.963
Donor age <0.01 1.037 1.026 1.049
MBP: Mean blood pressure; DGF: delayed graft function
https://doi.org/10.1371/journal.pone.0249552.t006
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challenge [15]. No guideline or recommendation is to date available for catecholamine choice/
dosage [15, 23] as for intraoperative fluid amount and quality [24–26]. On the other hand, the
excessive use of inotropes [27] and fluid infusions [9], as observed in our population, were
both associated with adverse outcomes. A “goal-directed therapy,” borrowed from critical care
experience [28, 29], may represent the optimal approach in this setting, although no studies
are currently available in KTs [15].
We acknowledge that our study has some limitations: the retrospective design, the limited
number of postoperative data. However, all 1127 patients underwent the same surgical and
clinical management and a subsequent strict and continuous monitorization with a precise
schedule followed by our team of transplant nephrologists; additionally, the adopted multivari-
ate model and paired kidney analysis reduced the effect of possible confounders.
In conclusion, pre-existing chronic hypotension is the only modifiable condition with a sig-
nificant and independent association with post-KT DGF occurrence.
Based on our analysis results, we would also highlight the association between hypotension
and reduced death-censored graft survival in elderly patients, suggesting that hypotension-
mediated DGF may become more critical in the setting of the so-called “suboptimal” donors,
stressing the importance of therapeutic strategies implementation in this area.
Allocation and institutional policies should carefully consider patients with pre-existing
chronic hypotension primarily when expanded-criteria donors are used, focusing on maximiz-
ing patient outcomes through a corresponding system resource implementation.
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